Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E–deficient mice
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 109, 1445-1453
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Tianjin Municipality (16JCYBC25500)
This publication has 20 references indexed in Scilit:
- Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbitsLipids in Health and Disease, 2013
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- The Role of Endoplasmic Reticulum Stress in the Progression of AtherosclerosisCirculation Research, 2010
- Endoplasmic reticulum stress and atherosclerosisNature Medicine, 2010
- Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic DiseaseCell, 2010
- Probucol markedly reduces HDL phospholipids and elevated preβ1-HDL without delayed conversion into α-migrating HDL: Putative role of angiopoietin-like protein 3 in probucol-induced HDL remodelingAtherosclerosis, 2008
- A Uniqe Antilipidemic Drug — ProbucolJournal of Atherosclerosis and Thrombosis, 2008
- Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- ProbucolDrugs, 1989